Edgewell delivered modest revenue growth in Q1 fiscal 2026 but reported an operating loss as inflation, restructuring charges, and mix pressures weighed on margins despite solid performance in Sun and Skin Care.
Net sales increased modestly year over year on a continuing operations basis.
Gross margin declined due to inflation, tariffs, and volume absorption.
Sun and Skin Care delivered strong organic growth driven by Sun Care.
Adjusted operating income and EBITDA declined versus the prior year.
The company reaffirmed its full-year fiscal 2026 outlook for continuing operations following the divestiture of the Feminine Care business.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance